Issued Patents All Time
Showing 25 most recent of 88 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12364661 | Deformable nano-scale vehicles (DNVS) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery | Ichiro Nishimura, Naren Subbiah, Jesus Campagna, Patricia Spilman, Mohammad Parvez Alam | 2025-07-22 |
| 12157740 | Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau | Dale E. Bredesen, Patricia Spilman, Barbara Jagodzinska | 2024-12-03 |
| RE49873 | APP specific bace inhibitors (ASBIs) and uses thereof | Dale E. Bredesen | 2024-03-19 |
| 11370793 | Triazolopyridines and triazolopyrimidines that lower stress-induced p-tau | Oleksandr Buzko, Dale E. Bredesen, Patricia Spilman, Barbara Jagodzinska | 2022-06-28 |
| 11325904 | Tropinol esters and related compounds to promote normal processing of APP | Dale E. Bredesen | 2022-05-10 |
| 11247974 | Small molecules that enable cartilage rejuvenation | Denis Evseenko, Benjamin J. Van Handel | 2022-02-15 |
| 11243215 | 3D-exoquant method for the analysis of surface molecules and quantification of tissue-specific exosomes in biological fluids | Jesus Campagna, Tina Bilousova, Patricia Spilman, Peter James Heinzelman, Asa Hatami +1 more | 2022-02-08 |
| 11142505 | Compositions for APP-selective BACE inhibition and uses therefor | Patricia Spilman, Barbara Jagodzinska | 2021-10-12 |
| 11091444 | Hydantoins that modulate BACE-mediated app processing | Dale E. Bredesen | 2021-08-17 |
| 11077108 | Allosteric corticotropin-releasing factor receptor 1 (CRFR1) antagonists that decrease p-tau and improve cognition | Mohammad Parvez Alam, Barbara Jagodzinska | 2021-08-03 |
| 11072592 | Small molecules that enable cartilage rejuvenation | Denis Evseenko, Benjamin J. Van Handel | 2021-07-27 |
| 10947207 | GP130 modulators | Mohammad Parvez Alam, Patricia Spilman, Kanagasabai Vadivel | 2021-03-16 |
| 10844071 | Substituted [1,2,3]triazolo[4,5-d]pyrimidines that lower stress-induced p-tau | Dale E. Bredesen | 2020-11-24 |
| 10835546 | App specific BACE inhibitors (ASBIs) and uses thereof | Dale E. Bredesen | 2020-11-17 |
| 10766867 | Hydantoins that modulate BACE-mediated APP processing | Dale E. Bredesen | 2020-09-08 |
| 10618899 | Substituted [1,2,3]triazolo[4,5-d]pyrimidines that lower stress-induced p-tau | Dale E. Bredesen | 2020-04-14 |
| 10449177 | Methods of treating mild cognitive impairment (MCI) and related disorders | Dale E. Bredesen | 2019-10-22 |
| 10357508 | APP specific BACE inhibitors (ASBIs) and uses thereof | Dale E. Bredesen | 2019-07-23 |
| 10202355 | Hydantoins that modulate bace-mediated app processing | Dale E. Bredesen | 2019-02-12 |
| 9926280 | Hydantoins that modulate BACE-mediated APP processing | Dale E. Bredesen | 2018-03-27 |
| 9534016 | Netrin loop peptide mimetics and uses thereof | Clare Peters-Libeu, Dale E. Bredesen | 2017-01-03 |
| 7858642 | Substituted hydroxyethylamine aspartyl protease inhibitors | Michel Maillard, John Tucker, Jose Aquino, Barbara Jagodzinska, Louis Brogley +5 more | 2010-12-28 |
| 7763646 | Compounds for the treatment of alzheimer's disease | Roy Hom | 2010-07-27 |
| 7727997 | N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives | Michel Maillard, Barbara Jagodzinska, James P. Beck, Andrea Gailunas, John N. Freskos +6 more | 2010-06-01 |
| 7645780 | Acetyl 2-hydroxy-1, 3-diaminoalkanes | Michel Maillard, James P. Beck, Eric T. Baldwin, Robert Owen Hughes, Shon Pulley +1 more | 2010-01-12 |